NCT06976554

Brief Summary

Mechanical ventilation is a commonly used life-saving hospital procedure for patients with severe breathing difficulty. Some patients have difficulty separating from the ventilator and need to be removed gradually. This process is called ventilator weaning. It is not known what is the best way to wean patients from the ventilator. In this study, the investigators will compare two commonly used ventilator weaning strategies and compare their success. One ventilator strategy, the Pressure Support Ventilation weaning (PSV), combines 12 hours ventilator weaning with 12 hours rest on the ventilator. This strategy is faster with an anticipated weaning in 2 weeks. The other strategy, the Therapist implemented Patient Specific weaning (TIPS), gradually lowers support and weans in 3 weeks. Patients admitted to Barlow Respiratory Hospital (BRH) for ventilator weaning will be asked to participate in this study within 72 hours of hospital admission. Participants will undergo a spontaneous breathing trial (SBT) to assess your ability to breathe while receiving minimal or no ventilator support. Patients who pass SBT will be eligible for cool aerosol trials (humidified, oxygenated air without positive pressure mechanical ventilation). Participants who fail SBT within 24 hours will be eligible for the study. Participants will be randomized to receive PSV or TIPS ventilator weaning. The investigators will collect clinical, laboratory and mechanical ventilator information throughout the study period. Ventilator weaning success will be compared at day 30. The study will not interfere with any components of clinical care but the study investigators will be allowed to change the ventilator weaning strategy from PSV to TIPS, if a participant is unable to tolerate PSV weaning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 16, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2025

Completed
Last Updated

August 3, 2025

Status Verified

August 1, 2025

Enrollment Period

1.8 years

First QC Date

April 28, 2025

Last Update Submit

August 1, 2025

Conditions

Keywords

prolonged mechanical ventilationventilator weaningtracheostomy

Outcome Measures

Primary Outcomes (1)

  • weaning success

    Patients who can disconnect from the mechanical ventilator for 3 consecutive days or have their tracheostomy decannulated will be considered weaned ("success") and will have completed the protocol.

    30 days

Secondary Outcomes (5)

  • tracheostomy decannulation

    30 days

  • hospital length of stay

    throughout study completion, an average 90 days

  • intensive care unit admissions

    30 days

  • in-hospital mortality

    throughout study completion, an average 90 days

  • physical activity score

    throughout study completion, an average 90 days

Study Arms (2)

Therapist-implemented patient-specific (TIPS) ventilator weaning

ACTIVE COMPARATOR

In the TIPS path, participants will complete a 21 step protocol. Mechanical ventilator (MV) weaning is done with synchronized intermittent mandatory ventilation (SIMV) mode for 24 hrs. Patients will transition to this mode on the Day 1 (D1) after completion of SBT. The initial ventilator setup is PS 20 cmH2O PEEP 5cmH2O set RR 10/min. During the first 4 steps the backup rate will be lowered gradually from 8/min to 4/min (Step 1-4). Subsequently the PS will be reduced from 20 to 10 by each step (Step 5-9). SBT is performed in Step 10 with 1 hr. CA trials. ABG is performed in Step 11 with 2 hrs. of CA to assure respiratory stability. Patients rest on SIMV PS=10 cmH2O PEEP=5cmH2O, RR=4 (Step 9) setting during CA trial. Subjects can progress up to 3 steps daily, if deemed able by the respiratory therapist. The protocol completes when the patients is able to complete 72 hours of continuous CA time.

Procedure: weaning

Pressure support ventilation (PSV) weaning

ACTIVE COMPARATOR

In the PSV path, participants will complete a 14-step protocol. In this protocol gradual decrease of PS is used for 10-12 hrs. a day. PS is decreased from 20cmH2O to 10cmH2O with 5cmH2O PEEP applied (Step 1-6). Every weaning step is followed by rest on the same ventilator setting the patient had on admission. Starting Step 7, subjects will undergo daily SBT (1 hour 5cmH2O PS with 5cmH2O PEEP). If they pass, they will progress to CA trials (Step 8-14). ABG is performed after 2 hours of CA time in Step 7 to assure respiratory stability. CA time will be extended by 4 hrs. in Step 8 to 14. Patients rest on the admission ventilator settings. Subjects can progress up to 3 steps daily, if deemed able by the respiratory therapist. The protocol completes when the patients is able to complete 72 hrs. of continuous CA time.

Procedure: weaning

Interventions

weaningPROCEDURE

gradual weaning from the mechanical ventilator

Pressure support ventilation (PSV) weaningTherapist-implemented patient-specific (TIPS) ventilator weaning

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients requiring positive pressure mechanical ventilation for at least 21 days prior to BRH admission and
  • Have a secure tracheostomy.

You may not qualify if:

  • Inability to obtain informed consent from patient or DPOA
  • Incarcerated patients
  • Patients with less than 3 months of life expectancy
  • Patients requiring vasopressor medication to stabilize blood pressure on admission
  • Systolic blood pressure less than 90mmHg on admission
  • Pulse less than 50 or greater than 130 beats per minute or change by more than 20 from baseline on admission
  • Respiratory rate greater than 35/min
  • Oxygen saturation less than 90%
  • PEEP\>5cmH2O
  • Lung tidal volume less than 250ml despite MV support
  • At least one previous admission to BRH with unsuccessful ventilator liberation attempt
  • Length of Stay (LOS) at BRH less than 24hours
  • Patients pass spontaneous breathing trial (SBT) on D1 and eligible for cool aerosol, except if they fail SBT on D2 and require continued MV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barlow Respiratory Hospital

Los Angeles, California, 90026, United States

Location

MeSH Terms

Interventions

Weaning

Intervention Hierarchy (Ancestors)

Infant Nutritional Physiological PhenomenaChild Nutritional Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Randomized to intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Clinical Professor

Study Record Dates

First Submitted

April 28, 2025

First Posted

May 16, 2025

Study Start

September 1, 2023

Primary Completion

June 30, 2025

Study Completion

July 29, 2025

Last Updated

August 3, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Only deidentified data will be shared with the study team. This includes health demographics, comorbidities, blood laboratory values, vital signs, ventilator parameters, antibiotics, vasopressors use, health outcomes and discharge location.

Locations